The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Dynavax Technologies; Dynavax Technologies; Dynavax Technologies; Dynavax Technologies; Incyte; Incyte; Incyte; Incyte
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Dynavax Technologies; Dynavax Technologies; Dynavax Technologies; Dynavax Technologies; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Genentech; Genentech; Genentech; Genentech; Incyte; Incyte; Incyte; Incyte; Merck; Merck; Merck; Merck; Transgene; Transgene; Transgene; Transgene
A pilot study of intratumoral SD-101 (toll-like receptor 9 agonist), nivolumab, and radiotherapy for treatment of chemotherapy-refractory metastatic pancreatic adenocarcinoma.
 
Justin Chen
No Relationships to Disclose
 
Jasmine Huynh
No Relationships to Disclose
 
Arta Monjazeb
No Relationships to Disclose
 
May Thet Cho
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
 
Edward Jae-Hoon Kim
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene
Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); EpicentRx (Inst); EpicentRx (Inst); EpicentRx (Inst); EpicentRx (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst); Samumed (Inst); Samumed (Inst); Samumed (Inst); Samumed (Inst)